Ruth Tal‐Singer

Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients

Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies

Patient Insights on Living With Type 2 Inflammation: A Community Survey

Multi-morbidity in Type 2 Disease: A Patient and Providers Survey

Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk

Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings

An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials

Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium

Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective

Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD

Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers

Objectively Measured Physical Activity as a COPD Clinical Trial Outcome

Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease

Machine Learning and Prediction of All-Cause Mortality in COPD

Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD

<p>Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort</p>

New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries

Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease

It’s more than low BMI: prevalence of cachexia and associated mortality in COPD

At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

Physical activity patterns and clusters in 1001 patients with COPD

Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects

Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity

Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression